Charming Medical Limited Class A Ordinary Shares
Charming Medical Limited Class A Ordinary Shares Fundamental Analysis
Charming Medical Limited Class A Ordinary Shares (MCTA) shows weak financial fundamentals with a PE ratio of 414.66, profit margin of 19.27%, and ROE of -2.33%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -268.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze MCTA's fundamental strength across five key dimensions:
Efficiency Score
ExcellentMCTA demonstrates superior asset utilization.
Valuation Score
WeakMCTA trades at a premium to fair value.
Growth Score
ModerateMCTA shows steady but slowing expansion.
Financial Health Score
WeakMCTA carries high financial risk with limited liquidity.
Profitability Score
ModerateMCTA maintains healthy but balanced margins.
Key Financial Metrics
Is MCTA Expensive or Cheap?
P/E Ratio
MCTA trades at 414.66 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, MCTA's PEG of 4.15 indicates potential overvaluation.
Price to Book
The market values Charming Medical Limited Class A Ordinary Shares at 10097.17 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 258.92 times EBITDA. This signals the market has high growth expectations.
How Well Does MCTA Make Money?
Net Profit Margin
For every $100 in sales, Charming Medical Limited Class A Ordinary Shares keeps $19.27 as profit after all expenses.
Operating Margin
Core operations generate 22.32 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-2.33 in profit for every $100 of shareholder equity.
ROA
Charming Medical Limited Class A Ordinary Shares generates $22.39 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Charming Medical Limited Class A Ordinary Shares generates limited operating cash flow of $381.63K, signaling weaker underlying cash strength.
Free Cash Flow
Charming Medical Limited Class A Ordinary Shares generates weak or negative free cash flow of $123.98K, restricting financial flexibility.
FCF Per Share
Each share generates $0.01 in free cash annually.
FCF Yield
MCTA converts 0.03% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
414.66
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
4.15
vs 25 benchmark
P/B Ratio
Price to book value ratio
10097.17
vs 25 benchmark
P/S Ratio
Price to sales ratio
71.61
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
23.57
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.68
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-2.33
vs 25 benchmark
ROA
Return on assets percentage
0.22
vs 25 benchmark
ROCE
Return on capital employed
3.41
vs 25 benchmark
How MCTA Stacks Against Its Sector Peers
| Metric | MCTA Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 414.66 | 29.45 | Worse (Expensive) |
| ROE | -232.79% | 779.00% | Weak |
| Net Margin | 19.27% | -24936.00% (disorted) | Strong |
| Debt/Equity | 23.57 | 0.26 | Weak (High Leverage) |
| Current Ratio | 0.68 | 4.65 | Weak Liquidity |
| ROA | 22.39% | -19344.00% (disorted) | Strong |
MCTA outperforms its industry in 2 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Charming Medical Limited Class A Ordinary Shares's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation